
EquityEquity - OtherVery High Risk
NAV (03-Nov-25)
Returns (Since Inception)
Fund Size
₹420 Cr
Expense Ratio
0.47%
ISIN
INF769K01KU7
Minimum SIP
-
Exit Load
-
Inception Date
23 Oct 2023
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-3.02%
— (Cat Avg.)
Since Inception
+23.23%
— (Cat Avg.)
| Equity | ₹420.18 Cr | 100.03% |
| Others | ₹-0.12 Cr | -0.03% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Fortis Healthcare Ltd | Equity | ₹21.86 Cr | 5.20% |
| Coforge Ltd | Equity | ₹21.27 Cr | 5.06% |
| BSE Ltd | Equity | ₹21.26 Cr | 5.06% |
| Max Financial Services Ltd | Equity | ₹20.28 Cr | 4.83% |
| One97 Communications Ltd | Equity | ₹20.16 Cr | 4.80% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹19.4 Cr | 4.62% |
| Dixon Technologies (India) Ltd | Equity | ₹16.56 Cr | 3.94% |
| Eternal Ltd | Equity | ₹16.51 Cr | 3.93% |
| Muthoot Finance Ltd | Equity | ₹16.11 Cr | 3.84% |
| HDFC Asset Management Co Ltd | Equity | ₹15.67 Cr | 3.73% |
| Solar Industries India Ltd | Equity | ₹15.62 Cr | 3.72% |
| Bharat Electronics Ltd | Equity | ₹15.47 Cr | 3.68% |
| Eicher Motors Ltd | Equity | ₹14.8 Cr | 3.52% |
| Bosch Ltd | Equity | ₹13.93 Cr | 3.32% |
| Bajaj Finance Ltd | Equity | ₹13.79 Cr | 3.28% |
| Indian Hotels Co Ltd | Equity | ₹12.59 Cr | 3.00% |
| TVS Motor Co Ltd | Equity | ₹12.18 Cr | 2.90% |
| UPL Ltd | Equity | ₹11.67 Cr | 2.78% |
| Bharti Airtel Ltd | Equity | ₹11.4 Cr | 2.71% |
| Maruti Suzuki India Ltd | Equity | ₹11.29 Cr | 2.69% |
| Aditya Birla Capital Ltd | Equity | ₹10.91 Cr | 2.60% |
| Mahindra & Mahindra Ltd | Equity | ₹10.88 Cr | 2.59% |
| Divi's Laboratories Ltd | Equity | ₹10.81 Cr | 2.57% |
| Indian Bank | Equity | ₹10.67 Cr | 2.54% |
| InterGlobe Aviation Ltd | Equity | ₹10.57 Cr | 2.52% |
| Mazagon Dock Shipbuilders Ltd | Equity | ₹10.25 Cr | 2.44% |
| HDFC Bank Ltd | Equity | ₹10.06 Cr | 2.40% |
| L&T Finance Ltd | Equity | ₹9.92 Cr | 2.36% |
| SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹7.49 Cr | 1.78% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹6.78 Cr | 1.61% |
| Net Receivables / (Payables) | Cash | ₹-6.61 Cr | 1.57% |
| Treps | Cash - Repurchase Agreement | ₹6.49 Cr | 1.54% |
Large Cap Stocks
46.57%
Mid Cap Stocks
53.46%
Small Cap Stocks
--
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Financial Services | ₹136.18 Cr | 32.42% |
| Consumer Cyclical | ₹92.19 Cr | 21.95% |
| Healthcare | ₹58.85 Cr | 14.01% |
| Technology | ₹57.99 Cr | 13.80% |
| Industrials | ₹36.28 Cr | 8.64% |
| Basic Materials | ₹27.29 Cr | 6.50% |
| Communication Services | ₹11.4 Cr | 2.71% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better

Since October 2023
Since March 2025
ISIN INF769K01KU7 | Expense Ratio 0.47% | Exit Load - | Fund Size ₹420 Cr | Age 2 years | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty 200 Alpha 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹2,14,063 Cr
Address
Unit No. 606, 6th Floor, Mumbai, 400 098
Your principal amount will be at Very High Risk


EquityEquity - OtherVery High Risk
NAV (03-Nov-25)
Returns (Since Inception)
Fund Size
₹420 Cr
Expense Ratio
0.47%
ISIN
INF769K01KU7
Minimum SIP
-
Exit Load
-
Inception Date
23 Oct 2023
Your principal amount will be at Very High Risk

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-3.02%
— (Cat Avg.)
Since Inception
+23.23%
— (Cat Avg.)
| Equity | ₹420.18 Cr | 100.03% |
| Others | ₹-0.12 Cr | -0.03% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Fortis Healthcare Ltd | Equity | ₹21.86 Cr | 5.20% |
| Coforge Ltd | Equity | ₹21.27 Cr | 5.06% |
| BSE Ltd | Equity | ₹21.26 Cr | 5.06% |
| Max Financial Services Ltd | Equity | ₹20.28 Cr | 4.83% |
| One97 Communications Ltd | Equity | ₹20.16 Cr | 4.80% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹19.4 Cr | 4.62% |
| Dixon Technologies (India) Ltd | Equity | ₹16.56 Cr | 3.94% |
| Eternal Ltd | Equity | ₹16.51 Cr | 3.93% |
| Muthoot Finance Ltd | Equity | ₹16.11 Cr | 3.84% |
| HDFC Asset Management Co Ltd | Equity | ₹15.67 Cr | 3.73% |
| Solar Industries India Ltd | Equity | ₹15.62 Cr | 3.72% |
| Bharat Electronics Ltd | Equity | ₹15.47 Cr | 3.68% |
| Eicher Motors Ltd | Equity | ₹14.8 Cr | 3.52% |
| Bosch Ltd | Equity | ₹13.93 Cr | 3.32% |
| Bajaj Finance Ltd | Equity | ₹13.79 Cr | 3.28% |
| Indian Hotels Co Ltd | Equity | ₹12.59 Cr | 3.00% |
| TVS Motor Co Ltd | Equity | ₹12.18 Cr | 2.90% |
| UPL Ltd | Equity | ₹11.67 Cr | 2.78% |
| Bharti Airtel Ltd | Equity | ₹11.4 Cr | 2.71% |
| Maruti Suzuki India Ltd | Equity | ₹11.29 Cr | 2.69% |
| Aditya Birla Capital Ltd | Equity | ₹10.91 Cr | 2.60% |
| Mahindra & Mahindra Ltd | Equity | ₹10.88 Cr | 2.59% |
| Divi's Laboratories Ltd | Equity | ₹10.81 Cr | 2.57% |
| Indian Bank | Equity | ₹10.67 Cr | 2.54% |
| InterGlobe Aviation Ltd | Equity | ₹10.57 Cr | 2.52% |
| Mazagon Dock Shipbuilders Ltd | Equity | ₹10.25 Cr | 2.44% |
| HDFC Bank Ltd | Equity | ₹10.06 Cr | 2.40% |
| L&T Finance Ltd | Equity | ₹9.92 Cr | 2.36% |
| SBI Cards and Payment Services Ltd Ordinary Shares | Equity | ₹7.49 Cr | 1.78% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹6.78 Cr | 1.61% |
| Net Receivables / (Payables) | Cash | ₹-6.61 Cr | 1.57% |
| Treps | Cash - Repurchase Agreement | ₹6.49 Cr | 1.54% |
Large Cap Stocks
46.57%
Mid Cap Stocks
53.46%
Small Cap Stocks
--
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Financial Services | ₹136.18 Cr | 32.42% |
| Consumer Cyclical | ₹92.19 Cr | 21.95% |
| Healthcare | ₹58.85 Cr | 14.01% |
| Technology | ₹57.99 Cr | 13.80% |
| Industrials | ₹36.28 Cr | 8.64% |
| Basic Materials | ₹27.29 Cr | 6.50% |
| Communication Services | ₹11.4 Cr | 2.71% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better

Since October 2023
Since March 2025
ISIN INF769K01KU7 | Expense Ratio 0.47% | Exit Load - | Fund Size ₹420 Cr | Age 2 years | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty 200 Alpha 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹2,14,063 Cr
Address
Unit No. 606, 6th Floor, Mumbai, 400 098
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments